archive-ie.com » IE » N » NCRI.IE

Total: 1177

Choose link from "Titles, links and description words view":

Or switch to "Titles and links view".
  • Economic impact of cancer in Ireland | National Cancer Registry Ireland
    better understand this issue It has two major components 1 estimation of the costs of colorectal cancer from a range of perspectives and 2 evaluation of the cost effectiveness of the options for prevention of colorectal cancer The first component involves estimating the costs of cancer for patients and their family members informal caregivers the health services and society as whole To estimate patient and caregiver costs we undertook in depth interviews with survivors and family members and based on these developed questionnaires to assess out of pocket costs and time foregone The survivor survey was administered to colorectal cancer survivors identified from the National Cancer Registry Caregivers were identified through participating survivors and invited to complete the family member survey These questionnaires also collected information on health related quality of life utility financial impact of cancer and caregiver burden Treatment data from the National Cancer Registry was supplemented by microcosting studies to estimate health service costs Societal costs were estimated in terms of lost productivity due to cancer using data from the survivor survey and the National Cancer Registry Further work on productivity costs can be found here The second component involved an assessment of the cost effectiveness of a range of options for a population based colorectal cancer screening programme in Ireland faecal occult blood testing faecal immunochemical testing and flexible sigmoidoscopy More information about this work can be found here This was supplemented by systematic reviews on other screening modalities including faecal DNA testing and CT colongraphy Data collection for the study is complete further papers are in preparation Related papers Cost effectiveness of faecal DNA screening for colorectal cancer A systematic review and quality appraisal of the literature Factors affecting receipt of medical card in a cohort of colorectal cancer patients in Ireland 2002 2006 Time

    Original URL path: http://www.ncri.ie/research/projects/economic-impact-cancer-ireland (2014-07-21)
    Open archived version from archive


  • Effect of social and spatial isolation among cancer patients on treatment receipt and survival | National Cancer Registry Ireland
    Home Research Research projects Effect of social and spatial isolation among cance Research themes Descriptive epidemiology Health services research Aetiological research Research projects Research publications Research reports Scientific papers Presentations Research partners Research team Status Ongoing Cancer s Colorectal Non Hodgkin s lymphoma Research theme s Descriptive epidemiology Research workstream s Cancer survival Patterns determinants and experiences of cancer treatment Related staff Dr Marianna de Camargo Cancela former staff Prof Linda Sharp Dr Harry Comber Retired Collaborators co investigators Mr Trutz Haase Dr Howard Johnson Dr Jonathan Pratschke Funding source Irish Cancer Society This study aims to a investigate how aspects of social and spatial isolation among cancer patients influence treatment receipt and survival and b identify factors which if modified could improve equity and translate into better patient outcomes The study is investigating relationships between measures of social and spatial isolation e g age living alone geographical isolation access to transport distance to health services and low mobility and treatment receipt and survival mortality in patients diagnosed with colorectal cancer or non Hodgkin s lymphoma between 2004 2008 Data sources for the project include 1 demographic cancer and treatment data from the National Cancer Registry 2 2006 census data on distance to hospital density of general practitioners deprivation mobility accessibility and living alone linked through address mapping to patients area of residence using a new classification which includes 18 488 areas and 3 measures of co morbidity derived from hospital in patient episodes HIPE linked to individual cancer patients Outcome measures will be i types of treatments received within the first year after diagnosis e g cancer directed surgery radiotherapy chemotherapy analysed individually and in combination and ii relative and cause specific survival Analyses will incorporate variables measured at the individual e g age marital status distance consultant e

    Original URL path: http://www.ncri.ie/research/projects/effect-social-and-spatial-isolation-among-cancer-patients-treatment-receipt-and (2014-07-21)
    Open archived version from archive

  • Effectiveness of breast screening: interval cancers in BreastCheck | National Cancer Registry Ireland
    us About our data how we collect it Using interpreting our data Cancer information Troubleshooting Effectiveness of breast screening interval cancers in BreastCheck Home Research Research projects Effectiveness of breast screening interval cancer Research themes Descriptive epidemiology Health services research Aetiological research Research projects Research publications Research reports Scientific papers Presentations Research partners Research team Status Dissemination Cancer s Breast Research theme s Health services research Research workstream s Cancer screening Related staff Dr Katie O Brien Dr Harry Comber Retired Prof Linda Sharp Collaborators co investigators BreastCheck The national breast screening programme Funding source National Cancer Registry Ireland The ultimate aim of breast screening is the reduction of breast cancer mortality in the population Any effects of screening on mortality are likely to take several years to accrue In the meantime examination of interval cancer rates that is the cancers diagnosed in women in the interval between screening rounds can provide an early indication of programme quality and effectiveness BreastCheck commenced in Ireland in 2000 and was extended to the rest of the country in 2007 BreastCheck routinely provide data to the National Cancer Registry on women who have attended for screening The National Cancer Registry links this to

    Original URL path: http://www.ncri.ie/research/projects/effectiveness-breast-screening-interval-cancers-breastcheck (2014-07-21)
    Open archived version from archive

  • Effects of pharmacological exposure on Ovarian Cancer | National Cancer Registry Ireland
    Cancer Home Research Research projects Effects of pharmacological exposure on Ovarian Can Research themes Descriptive epidemiology Health services research Aetiological research Research projects Research publications Research reports Scientific papers Presentations Research partners Research team Status Ongoing Cancer s Ovary Research theme s Health services research Aetiological research Research workstream s Cancer survival Pharmaco epidemiology Related staff Mr Chris Brown Prof Linda Sharp Collaborators co investigators Dr Ian Barron Trinity College Dublin Dr Kathleen Bennett St James s Hospital Dublin Dr Chris Cardwell Queen s University Belfast Dr John Coulter South Infirmary Victoria University Hospital Cork Prof Carmel Hughes Queen s University Belfast Prof Liam Murray Queen s University Belfast Funding source Health Research Board Almost 250 000 ovarian cancers are diagnosed worldwide each year Incidence rates are high in northern Europe including in the Republic of Ireland RoI and the UK These countries have among the highest ovarian cancer mortality rates in the world The relatively young average age and advanced stage at diagnosis mean that ovarian cancer is a major burden Lab based research suggests that various commonly used drugs such as non steroidal anti inflammatory drugs might have potent anti tumour effects in ovarian cancer We are combining population based pharmacoepidemiology databases from RoI Northern Ireland and Great Britain to investigate associations between exposure to these three drug groups and ovarian cancer presentation progression and outcomes Phase I is investigating associations between pre diagnosis drug exposure and stage and grade at diagnosis Phase II is investigating associations between exposure to drugs and disease recurrence Phase III will investigate associations between exposure to drugs and mortality The study will provide valuable population based evidence on the effects of these common drugs on ovarian cancer and contribute to improved health outcomes for women by guiding future research in the area

    Original URL path: http://www.ncri.ie/research/projects/effects-pharmacological-exposure-ovarian-cancer (2014-07-21)
    Open archived version from archive

  • Content relating to cancer 'Ovary' | National Cancer Registry Ireland
    projections Statistical reports Cancer atlases Research publications Research reports Scientific papers Presentations All Ireland cancer statistics Infographics Research Research themes Descriptive epidemiology Health services research Aetiological research Research projects Research publications Research reports Scientific papers Presentations Research partners Research team FAQs All FAQs FAQs about us About our data how we collect it Using interpreting our data Cancer information Troubleshooting Content relating to cancer Ovary Home What we do Content relating to cancer Ovary News article Title Cancers Tags World Ovarian Cancer Day Ovary Infographic Factsheet Title Cancers Ovary Ovary Map Title Cancers Ovary 1994 2011 annual average Ovary Ovary 1994 2002 2003 2011 annual average Ovary Presentation Title Cancers Using routine prescribing data to identify comorbidities in ovarian cancer patients Ovary Marital status associated with ovarian cancer stage treatment and outcomes Ovary A profile of ovarian cancer incidence and treatment in Ireland 1994 2010 Ovary The link person The role of cancer nurse specialists in cancer treatment decisions Breast Colon Ovary Bias in prescription data of the Irish ovarian cancer population Ovary Publication Title Cancers Tags Cancer trends Cancers of the ovary Ovary Gynaecological Women Pages 1 2 next last Printer friendly version Building 6800 Cork Airport Business Park

    Original URL path: http://www.ncri.ie/cancers/ovary (2014-07-21)
    Open archived version from archive

  • Epidemiology of breast cancer subtypes in Ireland | National Cancer Registry Ireland
    themes Descriptive epidemiology Health services research Aetiological research Research projects Research publications Research reports Scientific papers Presentations Research partners Research team Status Complete Cancer s Breast Research theme s Descriptive epidemiology Health services research Research workstream s Cancer survival Patterns determinants and experiences of cancer treatment Related staff Dr Marianna de Camargo Cancela former staff Dr Harry Comber Retired Prof Linda Sharp Funding source Sanofi Breast cancer is a heterogeneous disease and tumour markers help to predict prognosis and to drive treatment decisions Unlike most cancer registries since 2002 the National Cancer Registry has collected information about the three main breast cancer tumour markers oestrogen receptor ER progesterone receptor PgR and human epidermal growth factor 2 HER2 A quality assurance exercise was conducted to maximise the available information on these tumour markers Following this each breast cancer case has been classified by subtype luminal A luminal B HER2 over expressing and triple negative The aim of this project was to investigate the epidemiology of different breast cancer subtypes at the population level The study has investigated i levels of testing for tumour markers and how this varies over time and across Ireland ii time trends in incidence of each subtype

    Original URL path: http://www.ncri.ie/research/projects/epidemiology-breast-cancer-subtypes-ireland (2014-07-21)
    Open archived version from archive

  • EU Pancreas - An integrated European platform for pancreas cancer research | National Cancer Registry Ireland
    All FAQs FAQs about us About our data how we collect it Using interpreting our data Cancer information Troubleshooting EU Pancreas An integrated European platform for pancreas cancer research Home Research Research projects EU Pancreas An integrated European platform for Research themes Descriptive epidemiology Health services research Aetiological research Research projects Research publications Research reports Scientific papers Presentations Research partners Research team Status Ongoing Cancer s Pancreas Research theme s Aetiological research Research workstream s Risk factors for cancer development Related staff Prof Linda Sharp Collaborators co investigators Dr Nuria Malats CNIO Spanish National Cancer Research Centre Dr Roger Milne CNIO Spanish National Cancer Research Centre Funding source European Commission Intergovernmental framework for European Cooperation in Science and Technology COST EU Pancreas An integrated European platform for pancreas cancer research from basic science to clinical and public health interventions for a rare disease is a European Union COST Action coordinated by Dr Nuria Malats of CNIO the Spanish National Cancer Research Centre The action brings together a network of researchers from across Europe who have an interest in pancreatic cancer The action which will run from 2012 until 2017 has established groups working in four priority areas Working group 1

    Original URL path: http://www.ncri.ie/research/projects/eu-pancreas-integrated-european-platform-pancreas-cancer-research (2014-07-21)
    Open archived version from archive

  • Content relating to cancer 'Pancreas' | National Cancer Registry Ireland
    Annual financial reports Cancer trends projections Statistical reports Cancer atlases Research publications Research reports Scientific papers Presentations All Ireland cancer statistics Infographics Research Research themes Descriptive epidemiology Health services research Aetiological research Research projects Research publications Research reports Scientific papers Presentations Research partners Research team FAQs All FAQs FAQs about us About our data how we collect it Using interpreting our data Cancer information Troubleshooting Content relating to cancer Pancreas Home What we do Content relating to cancer Pancreas Factsheet Title Cancers Pancreas Pancreas Map Title Cancers Pancreas 1994 2011 annual average Pancreas Pancreas 1994 2002 2003 2011 annual average Pancreas Publication Title Cancers Cancer trends Cancer of the pancreas Pancreas Research project Title Cancers EU Pancreas An integrated European platform for pancreas cancer research Pancreas PanCAM Pancreatic Cancer Aetiology Management Pancreas Consistency appropriateness and management of cancer services Breast Colorectal Gastric Head neck Lung Non Hodgkin s lymphoma Pancreas Prostate Scientific paper Title Cancers Mortality predictions for esophageal stomach and pancreatic cancer Ireland up to 2015 Oesophagus Pancreas Stomach Is there under treatment of pancreatic cancer Evidence from a population based study in Ireland Pancreas Printer friendly version Building 6800 Cork Airport Business Park Kinsale Road Cork Email info

    Original URL path: http://www.ncri.ie/cancers/pancreas (2014-07-21)
    Open archived version from archive



  •